Caffeine Guide: Effects, Doses, Dependence, Metabolism — What Science Says
Caffeine is the world's most widely consumed psychoactive substance. Found in coffee, tea, energy drinks, chocolate, and many over-the-counter medications, it affects several billion people every day. And yet, the actual understanding of how it works — how it acts on the brain, how long it stays in the body, what "tolerance" and "dependence" genuinely mean — remains surprisingly vague among most regular users. This guide draws on current scientific evidence to give you a clear and honest picture of caffeine in 2026.
How caffeine acts on the brain
Caffeine is not a stimulant in the strict pharmacological sense — it is an adenosine antagonist. Adenosine is an inhibitory neurotransmitter that accumulates in the brain throughout the day, progressively binding to receptors (primarily A1 and A2A) and signalling the central nervous system to slow down, ultimately producing the sensation of fatigue and the desire to sleep.
Caffeine's molecular structure resembles adenosine closely enough that it binds to the same receptors — but without activating them. By occupying the receptors without triggering the inhibitory signal, caffeine prevents adenosine from doing its job of slowing neural activity. Neurons continue firing normally, and the person experiences increased alertness and focus. Caffeine does not create energy: it temporarily suppresses the fatigue signal.
This mechanism also explains the "caffeine crash." When caffeine is metabolized and cleared from the receptors, the accumulated adenosine that was waiting to bind floods those now-unoccupied sites, sometimes producing a fatigue more pronounced than if no caffeine had been taken at all.
Metabolism: the CYP1A2 enzyme and genetic variation
Caffeine is metabolized primarily in the liver by the cytochrome P450 1A2 enzyme, encoded by the CYP1A2 gene. This enzyme converts caffeine into three primary metabolites: paraxanthine (≈84%), theobromine (≈12%), and theophylline (≈4%), each with distinct physiological effects.
The CYP1A2 gene carries important polymorphisms across the human population. Two broad groups can be identified:
- Fast metabolizers (CYP1A2*1A allele) — eliminate caffeine roughly twice as fast as the average. Half-life: 3 to 4 hours. Can drink coffee in the late afternoon with minimal impact on sleep. Roughly 40–50% of the Caucasian population.
- Slow metabolizers (CYP1A2*1F and other variants) — half-life of 7 to 10 hours or more. A 3 pm coffee is still significantly influencing sleep at 11 pm. Roughly 50–60% of the population.
Environmental factors also modulate metabolism: smoking accelerates CYP1A2 activity (smokers metabolize caffeine about 50% faster); hormonal contraception and pregnancy slow it considerably (half-life can reach 15 hours in the third trimester).
Caffeine content by drink
| Drink | Volume | Caffeine (mg) | Variability |
|---|---|---|---|
| Single espresso | 30 ml | 60–75 mg | Low (controlled method) |
| Double espresso | 60 ml | 120–150 mg | Low |
| Drip filter coffee | 200 ml | 80–120 mg | Medium (depends on ratio) |
| Pour-over (V60/Chemex) | 300 ml | 150–200 mg | Medium |
| Instant coffee | 200 ml | 60–100 mg | Low |
| Decaffeinated coffee | 200 ml | 5–15 mg | Low (residual traces) |
| Black tea | 200 ml | 40–70 mg | High (steep time, leaf grade) |
| Green tea | 200 ml | 20–50 mg | High |
| Red Bull (250 ml can) | 250 ml | 80 mg | None (declared) |
| Monster Energy (500 ml) | 500 ml | 160 mg | None |
| 70% dark chocolate (30 g) | 30 g | 20–30 mg | Medium |
Recommended doses and safety thresholds
The European Food Safety Authority (EFSA) and the US FDA align on a safety threshold of 400 mg of caffeine per day for healthy adults — roughly equivalent to 4 double espressos or 3 to 4 large filter coffees. Beyond this threshold, adverse effects (tachycardia, anxiety, insomnia, tremors) increase substantially.
Specific thresholds apply to particular populations:
- Pregnant women: 200 mg/day maximum (WHO, EFSA). Above this, increased risk of fetal growth restriction and adverse pregnancy outcomes.
- Children and adolescents: 3 mg/kg/day maximum according to EFSA — approximately 85 mg for a 28 kg child. Energy drinks are particularly concerning in this age group.
- People with heart conditions or anxiety disorders: medical consultation recommended before any regular consumption, as individual thresholds may be well below general limits.
Tolerance: what actually happens
Caffeine tolerance develops rapidly — within 3 to 7 days of regular consumption. Its mechanism is different from what most people assume: the brain does not become "insensitive" to caffeine. Instead, it upregulates adenosine receptor expression in response to chronic blockade. The result: the same caffeine dose blocks proportionally fewer receptors, and more caffeine is required to achieve the original effect.
This neuroadaptation is fully reversible. A break of 7 to 14 days is generally sufficient to reset: adenosine receptors return to baseline density and initial sensitivity to caffeine is restored. This is why periodic "caffeine breaks" are genuinely useful for regular consumers who want to maintain the substance's effectiveness.
Dependence and withdrawal: what the literature says
The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) officially recognizes "caffeine withdrawal" as a disorder and "caffeine use disorder" as a condition warranting further research. Classic addiction criteria (compulsivity, loss of control, continued use despite harm) apply only in rare extreme cases.
Withdrawal symptoms, however, are well-documented and affect the majority of regular consumers who stop abruptly. They typically appear 12 to 24 hours after the last dose and last 2 to 9 days:
- Headache (the most frequent and often most disabling symptom)
- Intense fatigue and sleepiness
- Irritability and mild low mood
- Difficulty concentrating
- Flu-like symptoms (nausea, muscle aches)
To minimize withdrawal: reduce consumption gradually by 10 to 25% per week rather than stopping abruptly. A gradual taper eliminates most symptoms.
Caffeine is a drug in the precise pharmacological sense — it alters central nervous system activity and creates physiological adaptation. It is also one of the very few psychoactive substances whose regular, moderate consumption is associated with measurable health benefits. Both of these facts coexist.